Id1 expression is transcriptionally regulated in radial growth phase melanomas

Byungwoo Ryu, Dave S. Kim, Amena M. DeLuca, Megan A. Healey, Shariff Dunlap, Mary Jo Fackler, James Herman, Rhoda M. Alani

Research output: Contribution to journalArticle

Abstract

Id genes have been demonstrated to be upregulated in a wide variety of human malignancies and their expression has been correlated with disease prognosis; however, little is known about the mechanisms of Id gene activation in tumors. We have previously shown that the helix-loop-helix transcription factor, Id1, is highly expressed in primary human melanomas during the radial growth phase and that Id1 is a transcriptional repressor of the familial melanoma gene CDKN2A. Here we use a series of melanoma cell lines that recapitulate the phenotypic characteristics of melanomas at varying stages of malignant progression to evaluate the expression levels of Id1 in this model system and determine the mechanism of Id1 dysregulation in these tumor cells. We find elevated protein levels of Id1 to be present consistently in radial growth phase tumor cells in accordance with our primary tumor data. Id1 transcript levels were also found to be elevated in these radial growth phase melanoma cells without any appreciable evidence of gene amplification and Id1 promoter activity was found to correlate with Id expression levels. We therefore conclude that Id1 expression is primarily regulated at the transcriptional level in radial growth phase melanomas and expect that therapies that target Id1 gene expression may be useful in the treatment of Id-associated malignancies.

Original languageEnglish (US)
Pages (from-to)1705-1709
Number of pages5
JournalInternational Journal of Cancer
Volume121
Issue number8
DOIs
StatePublished - Oct 15 2007

Fingerprint

Melanoma
Growth
Neoplasms
p16 Genes
Gene Amplification
Transcriptional Activation
Transcription Factors
Gene Expression
Cell Line
Genes
Proteins
Therapeutics

Keywords

  • Id1
  • Melanoma
  • Transcription

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ryu, B., Kim, D. S., DeLuca, A. M., Healey, M. A., Dunlap, S., Fackler, M. J., ... Alani, R. M. (2007). Id1 expression is transcriptionally regulated in radial growth phase melanomas. International Journal of Cancer, 121(8), 1705-1709. https://doi.org/10.1002/ijc.22875

Id1 expression is transcriptionally regulated in radial growth phase melanomas. / Ryu, Byungwoo; Kim, Dave S.; DeLuca, Amena M.; Healey, Megan A.; Dunlap, Shariff; Fackler, Mary Jo; Herman, James; Alani, Rhoda M.

In: International Journal of Cancer, Vol. 121, No. 8, 15.10.2007, p. 1705-1709.

Research output: Contribution to journalArticle

Ryu, B, Kim, DS, DeLuca, AM, Healey, MA, Dunlap, S, Fackler, MJ, Herman, J & Alani, RM 2007, 'Id1 expression is transcriptionally regulated in radial growth phase melanomas', International Journal of Cancer, vol. 121, no. 8, pp. 1705-1709. https://doi.org/10.1002/ijc.22875
Ryu, Byungwoo ; Kim, Dave S. ; DeLuca, Amena M. ; Healey, Megan A. ; Dunlap, Shariff ; Fackler, Mary Jo ; Herman, James ; Alani, Rhoda M. / Id1 expression is transcriptionally regulated in radial growth phase melanomas. In: International Journal of Cancer. 2007 ; Vol. 121, No. 8. pp. 1705-1709.
@article{a64186f35cb94757956e2e8484e67c09,
title = "Id1 expression is transcriptionally regulated in radial growth phase melanomas",
abstract = "Id genes have been demonstrated to be upregulated in a wide variety of human malignancies and their expression has been correlated with disease prognosis; however, little is known about the mechanisms of Id gene activation in tumors. We have previously shown that the helix-loop-helix transcription factor, Id1, is highly expressed in primary human melanomas during the radial growth phase and that Id1 is a transcriptional repressor of the familial melanoma gene CDKN2A. Here we use a series of melanoma cell lines that recapitulate the phenotypic characteristics of melanomas at varying stages of malignant progression to evaluate the expression levels of Id1 in this model system and determine the mechanism of Id1 dysregulation in these tumor cells. We find elevated protein levels of Id1 to be present consistently in radial growth phase tumor cells in accordance with our primary tumor data. Id1 transcript levels were also found to be elevated in these radial growth phase melanoma cells without any appreciable evidence of gene amplification and Id1 promoter activity was found to correlate with Id expression levels. We therefore conclude that Id1 expression is primarily regulated at the transcriptional level in radial growth phase melanomas and expect that therapies that target Id1 gene expression may be useful in the treatment of Id-associated malignancies.",
keywords = "Id1, Melanoma, Transcription",
author = "Byungwoo Ryu and Kim, {Dave S.} and DeLuca, {Amena M.} and Healey, {Megan A.} and Shariff Dunlap and Fackler, {Mary Jo} and James Herman and Alani, {Rhoda M.}",
year = "2007",
month = "10",
day = "15",
doi = "10.1002/ijc.22875",
language = "English (US)",
volume = "121",
pages = "1705--1709",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Id1 expression is transcriptionally regulated in radial growth phase melanomas

AU - Ryu, Byungwoo

AU - Kim, Dave S.

AU - DeLuca, Amena M.

AU - Healey, Megan A.

AU - Dunlap, Shariff

AU - Fackler, Mary Jo

AU - Herman, James

AU - Alani, Rhoda M.

PY - 2007/10/15

Y1 - 2007/10/15

N2 - Id genes have been demonstrated to be upregulated in a wide variety of human malignancies and their expression has been correlated with disease prognosis; however, little is known about the mechanisms of Id gene activation in tumors. We have previously shown that the helix-loop-helix transcription factor, Id1, is highly expressed in primary human melanomas during the radial growth phase and that Id1 is a transcriptional repressor of the familial melanoma gene CDKN2A. Here we use a series of melanoma cell lines that recapitulate the phenotypic characteristics of melanomas at varying stages of malignant progression to evaluate the expression levels of Id1 in this model system and determine the mechanism of Id1 dysregulation in these tumor cells. We find elevated protein levels of Id1 to be present consistently in radial growth phase tumor cells in accordance with our primary tumor data. Id1 transcript levels were also found to be elevated in these radial growth phase melanoma cells without any appreciable evidence of gene amplification and Id1 promoter activity was found to correlate with Id expression levels. We therefore conclude that Id1 expression is primarily regulated at the transcriptional level in radial growth phase melanomas and expect that therapies that target Id1 gene expression may be useful in the treatment of Id-associated malignancies.

AB - Id genes have been demonstrated to be upregulated in a wide variety of human malignancies and their expression has been correlated with disease prognosis; however, little is known about the mechanisms of Id gene activation in tumors. We have previously shown that the helix-loop-helix transcription factor, Id1, is highly expressed in primary human melanomas during the radial growth phase and that Id1 is a transcriptional repressor of the familial melanoma gene CDKN2A. Here we use a series of melanoma cell lines that recapitulate the phenotypic characteristics of melanomas at varying stages of malignant progression to evaluate the expression levels of Id1 in this model system and determine the mechanism of Id1 dysregulation in these tumor cells. We find elevated protein levels of Id1 to be present consistently in radial growth phase tumor cells in accordance with our primary tumor data. Id1 transcript levels were also found to be elevated in these radial growth phase melanoma cells without any appreciable evidence of gene amplification and Id1 promoter activity was found to correlate with Id expression levels. We therefore conclude that Id1 expression is primarily regulated at the transcriptional level in radial growth phase melanomas and expect that therapies that target Id1 gene expression may be useful in the treatment of Id-associated malignancies.

KW - Id1

KW - Melanoma

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=34548699659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548699659&partnerID=8YFLogxK

U2 - 10.1002/ijc.22875

DO - 10.1002/ijc.22875

M3 - Article

VL - 121

SP - 1705

EP - 1709

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -